ViroCell Biologics Retroviral & Lentiviral Vector CDMO
Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing
Notes from the Inside Viral Vector Science Videos + Webinars Articles
In the News Press Releases Conferences
Careers
Team ViroCell Leadership Team Scientific Advisory Board Board of Directors What we do Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing Innovative thinking Notes from the Inside Viral Vector Science Videos + Webinars Articles
ViroCell Biologics Retroviral & Lentiviral Vector CDMO
News In the News Press Releases Conferences Manufacturing dreams Careers Contact Us

When visionaries gather, progress follows. CAR-TCR Summit Series, Boston, Sept 23-26, 2025

Team ViroCell will be in Boston Sept 23-26 at @CAR-TCR Summit Series

We’d love to discuss your viral vector needs and challenges. Please contact Nicholas Ostrout, Ph.D. Elaine Rihn Makis Sigalas, PhD @johnwhadden

#viralvectors #genetherapy #lentiviralvectors #cellandgenetherapy #celltherapy #biotechInnovation #viralvectordesign #CARTCR25 #CARTCR

Florence BuchananSeptember 18, 2025
LinkedIn0 0 Likes
Previous

It’s great to be among great minds changing the cell and gene landscape. Meeting on the Mesa, Phoenix, Oct 6-8, 2025

Florence BuchananOctober 8, 2025
Next

Finding innovative approaches to viral vector challenges is what we do. Cell & Gene Therapy International, Boston, Sept 16-18 2025

Florence BuchananSeptember 17, 2025
 

Videos

 
 
watch

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

Get in touch
videosNewsroomCareersContact UsTerms of UsePrivacy Notice

London

 

ViroCell Holdings Limited (trading as ViroCell Biologics), registered in England and Wales, Company No. 16812976. Registered Office: 5 New Street Square, London EC4A 3TW ©2026 ViroCell Holdings Limited. All rights reserved.